Literature DB >> 6691897

Suppression of natural killer cell activity by adherent effusion cells of cancer patients. Suppression of motility, binding capacity and lethal hit of NK cells.

A Uchida, M Colot, M Micksche.   

Abstract

Adherent cells from carcinomatous pleural effusions of lung cancer patients were tested for their ability to suppress natural killer (NK) cell activity, and the mechanism involved in the suppression of NK cell activity was determined. Adherent effusion cells (AEC) were isolated from malignant pleural effusions of patients by centrifugation discontinuous Ficoll-Hypaque gradients and adherence to serum-coated plastic dishes, and large granular lymphocytes (LGL) were purified from the peripheral blood of normal individuals by centrifugation on discontinuous Percoll gradients and further depletion of high-affinity sheep erythrocyte rosette formation. LGL-mediated lysis of K562 cells was suppressed when LGL were cultured with AEC for 20 h, then washed and tested in a 4-h 51Cr release assay. More profound suppression of NK cell activity was observed when cytotoxicity was assayed in flat-bottomed wells rather than in round-bottomed wells. Cytotoxicity assays conducted at the single cell level in agarose revealed that the frequency of LGL binding to K562 cells and of dead conjugated target cells was reduced after overnight contact with AEC. In agarose microdroplet assays, functional LGL from normal donors exhibited definitive motility, expressing polarized shape. In contrast, a small number of LGL with non-polarized configuration migrated from the agarose droplet after overnight culture with AEC. These results indicate that functionally suppressed NK cells lose their motility, binding capacity and killing activity, which could be responsible for the suppression of NK cell activity by AEC.

Entities:  

Mesh:

Year:  1984        PMID: 6691897      PMCID: PMC1976666          DOI: 10.1038/bjc.1984.4

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice.

Authors:  A Tagliabue; R B Herberman; J L McCoy
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

2.  Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency.

Authors:  E Grimm; B Bonavida
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

3.  Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.

Authors:  C A Savary; E Lotzová
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

4.  The cytotoxic activity of human natural killer cells requires an intact secretory apparatus.

Authors:  O Carpén; I Virtanen; E Saksela
Journal:  Cell Immunol       Date:  1981-02       Impact factor: 4.868

5.  The dual effect of prostaglandin (PGE2) and ethanol on the natural killer cytolytic process: effector activation and NK-cell-target cell conjugate lytic inhibition.

Authors:  R A Kendall; S Targan
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

Review 6.  Do natural killer cells engage in regulated reactions against self to ensure homeostasis?

Authors:  G Cudkowicz; P S Hochman
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

7.  Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions.

Authors:  A Uchida; M Micksche
Journal:  Int J Cancer       Date:  1983-07-15       Impact factor: 7.396

8.  Suppression of activity of mouse natural killer (NK) cells by activated macrophages from mice treated with pyran copolymer.

Authors:  A Santoni; C Riccardi; T Barlozzari; R B Herberman
Journal:  Int J Cancer       Date:  1980-12-15       Impact factor: 7.396

9.  Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.

Authors:  T Timonen; J R Ortaldo; R B Herberman
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

10.  Recycling and target binding capacity of human natural killer cells.

Authors:  M Ullberg; M Jondal
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

2.  Lymphokine activated killer (LAK) cells in patients with gastrointestinal cancer.

Authors:  J R Monson; C W Ramsden; G R Giles; T G Brennan; P J Guillou
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

3.  Depressed natural killer cell activity in acute myocardial infarction.

Authors:  K Klarlund; B K Pedersen; T G Theander; V Andersen
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

4.  In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.

Authors:  A Uchida; E Yanagawa; E M Kokoschka; M Micksche; H S Koren
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

5.  Expanded human NK cells from lung cancer patients sensitize patients' PDL1-negative tumors to PD1-blockade therapy.

Authors:  Sophie M Poznanski; Tyrah M Ritchie; Isabella Y Fan; Abdullah El-Sayes; Ana L Portillo; Ronny Ben-Avi; Eduardo A Rojas; Marianne V Chew; Yaron Shargall; Ali A Ashkar
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 13.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.